Trial · NCT00925301
Participant flow56
How many started, completed or left each group, period by period.
1 to 20 of 56
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 6-Month Double-blind (Stage 1) | STARTED | Migalastat (0-6 Months) | 34 | |
| 6-Month Double-blind (Stage 1) | STARTED | Placebo (0-6 Months) | 33 | |
| 6-Month Double-blind (Stage 1) | STARTED | Migalastat (>6-12 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | STARTED | Migalastat (>12-24 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Received at Least 1 Dose of Study Drug | Migalastat (0-6 Months) | 34 | |
| 6-Month Double-blind (Stage 1) | Received at Least 1 Dose of Study Drug | Placebo (0-6 Months) | 33 | |
| 6-Month Double-blind (Stage 1) | Received at Least 1 Dose of Study Drug | Migalastat (>6-12 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Received at Least 1 Dose of Study Drug | Migalastat (>12-24 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Intent-to-Treat (ITT) | Migalastat (0-6 Months) | 34 | |
| 6-Month Double-blind (Stage 1) | Intent-to-Treat (ITT) | Placebo (0-6 Months) | 33 | |
| 6-Month Double-blind (Stage 1) | Intent-to-Treat (ITT) | Migalastat (>6-12 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Intent-to-Treat (ITT) | Migalastat (>12-24 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Modified Intent-to-Treat (mITT) | Migalastat (0-6 Months) | 30 | |
| 6-Month Double-blind (Stage 1) | Modified Intent-to-Treat (mITT) | Placebo (0-6 Months) | 30 | |
| 6-Month Double-blind (Stage 1) | Modified Intent-to-Treat (mITT) | Migalastat (>6-12 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | Modified Intent-to-Treat (mITT) | Migalastat (>12-24 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | COMPLETED | Migalastat (0-6 Months) | 34 | |
| 6-Month Double-blind (Stage 1) | COMPLETED | Placebo (0-6 Months) | 30 | |
| 6-Month Double-blind (Stage 1) | COMPLETED | Migalastat (>6-12 Months) | 0 | |
| 6-Month Double-blind (Stage 1) | COMPLETED | Migalastat (>12-24 Months) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00925301/flow